Patient preferences for reducing bowel adverse events following prostate radiotherapy.
BACKGROUND:The Extended Prostate Cancer Index Composite (EPIC) instrument is a commonly used patient reported outcome (PRO) tool in prostate cancer clinical trials. Summary scores for EPIC subscales are calculated by averaging patient scores for attributes (e.g., side effects), implying equal weight...
Main Authors: | Mark V Mishra, Winter Maxwell Thayer, Ellen Janssen, Bradford Hoppe, Caitlin Eggleston, John F P Bridges |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0235616 |
Similar Items
-
Factors that influence patient preferences for prostate cancer management options: a systematic review
by: Showalter TN, et al.
Published: (2015-07-01) -
Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy
by: Thomas Iseli, et al.
Published: (2020-09-01) -
Benefits and concerns of early adjuvant radiotherapy for prostate cancer with pathological adverse tumor characteristics
by: Victor Chia-Hsiang Lin
Published: (2015-12-01) -
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients
by: Davide Giuseppe Ribaldone, et al.
Published: (2019-08-01) -
Reducing preventable adverse drug events in hospital settings
by: Ramos, Gregg (Gregg Allen)
Published: (2008)